Receipt survey of prescription continuation rates for patients with onychomycosis and web‐based survey of dermatologists on prescribing policies for onychomycosis therapeutics
The Journal of Dermatology · 2024
DOI: 10.1111/1346-8138.17110 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Dermatology, 2024. Verfasst von Yuichiro Tsunemi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Saitama Medical University, Saitama, Japan. Hauptthemen laut MEDLINE: Onychomycosis, Foot Dermatoses. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: Sato Pharmaceutical, Eisai.
Abstract (Originalsprache)
Onychomycosis can be treated with topical and oral medications. However, it is important to appropriately select these medications according to the type and severity of the disease and ensure treatment is continued for the recommended duration. In Japan, treatment options for onychomycosis have increased in recent years. Moreover, in 2019, the guidelines for dermatomycosis treatment were revised. In this study, we conducted a receipt survey to clarify the actual treatment status of onychomycosis cases as indicated by the continuation rates of prescribed treatment drugs, together with a web‐based survey to ascertain the prescribing policy of dermatologists regarding drugs for onychomycosis treatment. In agreement with past surveys, this receipt survey showed that the prescription continuation rate for oral medications was higher than that for topical medications. The 1‐year prescription continuation rate for topical onychomycosis medications was found to be low (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Saitama Medical University, Saitama, Japan.
- Department of Dermatology, Faculty of Medicine, Kindai University, Osaka, Japan.
- Medical Affairs Department, Sato Pharmaceutical Co., Ltd., Tokyo, Japan.
ORCID-Profile: Yuichiro Tsunemi, Atsushi Otsuka, Yusuke Nonaka
Förderung
- Sato Pharmaceutical
- Eisai
Zitieren
APA
Tsunemi, Y., Otsuka, A., & Nonaka, Y. (2024). Receipt survey of prescription continuation rates for patients with onychomycosis and web‐based survey of dermatologists on prescribing policies for onychomycosis therapeutics. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17110
Vancouver
Tsunemi Y, Otsuka A, Nonaka Y. Receipt survey of prescription continuation rates for patients with onychomycosis and web‐based survey of dermatologists on prescribing policies for onychomycosis therapeutics. The Journal of Dermatology. 2024. doi:10.1111/1346-8138.17110
BibTeX
@article{Tsunemi2024,
author = {Tsunemi, Yuichiro and Otsuka, Atsushi and Nonaka, Yusuke},
title = {Receipt survey of prescription continuation rates for patients with onychomycosis and web‐based survey of dermatologists on prescribing policies for onychomycosis therapeutics},
journal = {The Journal of Dermatology},
year = {2024},
doi = {10.1111/1346-8138.17110}
}
EUVIMED